Date:
On May 11, 2022, Hunan Huize Biopharmaceutical Technology Co., Ltd. and Shenzhen Wahyong Analysis Instrument Co., Ltd. signed a strategic cooperation agreement in Changsha, Hunan. Based on the principles of sincere cooperation, mutual benefit, and common development, both parties have jointly established the "Drug Research and Development Joint Laboratory", which has been officially launched at Huize Research Institute.
Hunan Huize Biomedical Technology Co., Ltd. (referred to as Huize Pharmaceutical) is a CRO company committed to becoming a globally outstanding professional service platform for drug research and development and evaluation. It has the Hunan Engineering Research Center for Self emulsifying Technology Innovative Preparations, the Engineering Technology Research Center for Drug Formulation Optimization and Early Clinical Evaluation, the Biopharmacy and Pharmacokinetics Research Center, and the Clinical Evaluation Center for External Use Preparations Research platforms such as the Clinical Evaluation Center for Postmarket Drugs. It is reported that the innovative antibody drug pharmacokinetic model, local administration drug pharmacokinetic model, and drug formulation in vivo absorption and dissolution kinetics theory developed by the Huize scientific research team have received support from the National Natural Science Foundation of China. They have jointly established the National Skin Topical Drug Research Alliance with dozens of top tier hospitals in China, including Xiangya Hospital of Central South University, and have accumulated good clinical modeling experience in the field of long-acting injections and skin topical drugs.
Shenzhen Wahyong Analytical Instrument Co., Ltd. (abbreviated as Huarong Instrument) is a national high-tech enterprise specializing in the research and development, production, and sales of equipment for drug testing, laboratory pre-treatment, and other related fields. Our products cover fully automatic sampling and dissolution instruments, reciprocating cylinder dissolution instruments, flow cell dissolution instruments, transdermal diffusion systems, etc. We have over 40 independent intellectual property rights such as utility model patents, appearance patents, software copyrights, etc. We comply with USP and CHP standards and have passed ISO9001:2015 quality management system certification. At the same time, it also provides users with high-quality after-sales service and application support.
Through multiple rounds of technical consultations and research and development layout, Huize Pharmaceutical and Huarong Instrument have conducted in-depth exchanges and discussions on new technologies, products, policies and regulations. Both parties fully utilize their respective advantages and, through technological complementarity, take high-quality drug dissolution evaluation technology as the development direction. They lead the development and innovation of drug dissolution experiments and instruments with high precision and automation key technologies, promote the development of drug formulation research and consistency evaluation, and work together to create a high-performance drug dissolution detection technology and instrument equipment research and innovation platform. 
In the future, Wahyong Instrument will also work hand in hand with more high-quality enterprises to make contributions and efforts to promote and improve the development of the pharmaceutical industry!
